N-of-1 randomized trials to assess the efficacy of gabapentin for chronic neuropathic pain

Pain Medicine

Volumn 10, Issue 4, 2009, Pages 754-761

  Yelland, Michael J ^a   Poulos, Christopher J ^b   Pillans, Peter I ^c   Bashford, Guy M ^b   Nikles, Catherine Jane ^d   Sturtevant, Joanna M ^c   Vine, Norma ^e   Del Mar, Christopher B ^f   Schluter, Philip J ^d,g   Tan, Meng ^c   Chan, Jonathan ^h   Mackenzie, Fraser ⁱ   Brown, Robyn ^d  

^a GRIFFITH UNIVERSITY   (Australia)

^b Port Kembla Hospital   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^f BOND UNIVERSITY   (Australia)

^g AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ WESLEY HOSPITAL   (Australia)

Author keywords

Crossover trials; Gabapentin; Neuralgia; Pain; Randomized controlled trials

Indexed keywords

GABAPENTIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CHRONIC PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; FUNCTIONAL STATUS; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEUROPATHIC PAIN; OUTCOME ASSESSMENT; PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SLEEP PATTERN; TREATMENT DURATION; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; AMINES; ANALGESICS; CHRONIC DISEASE; CROSS-OVER STUDIES; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PLACEBOS; SLEEP DISORDERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67049109725     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2009.00615.x     Document Type: Article

References (19)

1. Mellegers MA, Furlan AD, Mailis A. Gabapentin for neuropathic pain: Systematic review of controlled and uncontrolled literature. Clin J Pain 2001;17(4):284-95.
2. Wiffen PJ, McQuay HJ, Edwards JE, Moore RA. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2005;(3):cD005452. DOI: 10.1002/ 14651858.CD005452.
3. Guyatt GH, Keller JL, Jaeschke R, et al. The n-of-1 randomized controlled trial: Clinical usefulness. Our three-year experience. Ann Intern Med 1990;112:293-9.
4. Nikles CJ, Clavarino AM, Del Mar CB. Using n-of-1 trials as a clinical tool to improve prescribing. Br J Gen Pract 2005;55:175-80.
5. Zucker DR, Schmid CH, McIntosh MW, et al. Combining single patient [N-of-1]trials to estimate population treatment effects and to evaluate individual patient responses to treatment. J Clin Epidemiol 1997;50:401-10.
6. Cepeda MS, Acevedo JC, Miranda N, Cortes C, Carr DB. An N-of-1 trial as an aid to decision-making prior to implanting a permanent spinal cord stimulator. Pain Med 2008;9(2):235-9.
7. Merskey H, Bogduk N. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. Seattle, WA: IASP Press; 1994:212.
8. Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other disease. Pain 1983;17:197-210.
9. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833-40.
10. Stratford PW, Gill C, Westaway M, Binkley J. Assessing disability and change in individual patients: A report of a patient-specific measure. Physiother Can 1995;47:258-63.
11. Ehrich EW, Davies GM, Watson DJ, et al. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol 2000;27(11):2635-41.
12. Zisapel N, Nir T. Determination of the minimal clinically significant difference on a patient visual analog sleep quality scale. J Sleep Res 2003;12(4):291-8.
13. Chatman AB, Hyams SP, Neel JM, et al. The Patient-Specific Functional Scale: Measurement properties in patients with knee dysfunction. Phys Ther 1997;77:820-9.
14. Yelland MJ, Nikles CJ, McNairn N, et al. Celecoxib compared with sustained-release paracetamol for osteoarthritis: A series of n-of-1 trials. Rheumatology (Oxford) 2007;46(1):135-40.
15. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA 1998;280(21):1831-6.
16. Rice AS, Maton S. Gabapentin in postherpetic neuralgia: A randomized, double blind, placebo controlled study. Pain 2001;94(2):215-24.
17. Larson EB. N-of-1 clinical trials. A technique for improving medical therapeutics. West J Med 1990;152:52-6.
18. Pincus T, Koch G, Lei H, et al. Patient preference for placebo, acetaminophen or celecoxib efficacy studies [PACES]: Two randomized placebo-controlled cross-over clinical trials in patients with osteoarthritis of the knee or hip. Ann Rheum Dis 2004;63:931-9.
19. Martin R, Vogtle L, Gilliam F, Faught E. Health-related quality of life in senior adults with epilepsy: What we know from randomized clinical trials and suggestions for future research. Epilepsy Behav 2003;4:626-34.